NICE Launches a competition for developers of healthcare technologies
NICE Scientific Advice has launched a competition for small or medium sized companies, charities and academic research groups, who are developing transformative products that have the potential to change patients’ lives and/or save the NHS money.
Latest news headlines
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
16 June 2017
A new deal on the breast cancer drug Kadcyla (also called trastuzumab emtansine and made by Roche) means that it can now be recommended for routine funding on the NHS.
15 June 2017
NICE to work with partners on developing new ways to measure quality of life across health and social care
NICE is taking part in a project that will examine how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health.
13 June 2017
NICE is launching an online tool to help medtech companies get their products to patients faster.
30 May 2017
As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
25 April 2017
NICE has published a draft standard aiming to improve end of life care for children in England.
18 April 2017